Form 4 for OKYO OKYO Pharma Ltd
Accepted 2022-05-20 00:00:00 ET · period of report 2022-05-19 · accession 0001493152-22-014552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-05-20 | 2022-05-19 | OKYO | CERRONE GABRIELE M | Executive COB, Dir | P - Purchase | $0.08 | +5.80M | 548.98M | +1% | +$464.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-05-19 | P | A | 5,800,000 | $0.08 | 548,981,215 | I Via Panetta Partners Limited | — | — |